Bonus BioGroup Ltd. (BONS.TA)
ILA 9.1
(0.0%)
ILA 9.1
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 29.82 Million ILS | -11.46% |
| 2022 | 33.68 Million ILS | -44.46% |
| 2021 | 60.63 Million ILS | 239.99% |
| 2020 | 17.83 Million ILS | -14.7% |
| 2019 | 20.9 Million ILS | 13.33% |
| 2018 | 18.45 Million ILS | -1.8% |
| 2017 | 18.78 Million ILS | 26.75% |
| 2016 | 14.82 Million ILS | 18.65% |
| 2015 | 12.49 Million ILS | 26.8% |
| 2014 | 9.85 Million ILS | 7.79% |
| 2013 | 9.14 Million ILS | 6.17% |
| 2012 | 8.61 Million ILS | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 7.21 Million ILS | -12.4% |
| 2024 Q1 | 8.23 Million ILS | 112.44% |
| 2023 Q4 | 3.87 Million ILS | -48.3% |
| 2023 Q3 | 7.49 Million ILS | 2.94% |
| 2023 FY | 29.82 Million ILS | -11.46% |
| 2023 Q1 | 8.18 Million ILS | 24.54% |
| 2023 Q2 | 7.28 Million ILS | -11.07% |
| 2022 Q3 | 8.26 Million ILS | -10.69% |
| 2022 Q2 | 9.25 Million ILS | -3.34% |
| 2022 FY | 33.68 Million ILS | -44.46% |
| 2022 Q1 | 9.57 Million ILS | 74.99% |
| 2022 Q4 | 6.57 Million ILS | -20.5% |
| 2021 Q1 | 36.76 Million ILS | 750.97% |
| 2021 Q3 | 10.37 Million ILS | 29.25% |
| 2021 Q4 | 5.47 Million ILS | -47.24% |
| 2021 FY | 60.63 Million ILS | 239.99% |
| 2021 Q2 | 8.02 Million ILS | -78.16% |
| 2020 Q2 | 4.15 Million ILS | -17.74% |
| 2020 FY | 17.83 Million ILS | -14.7% |
| 2020 Q4 | 4.32 Million ILS | 0.26% |
| 2020 Q3 | 4.3 Million ILS | 3.71% |
| 2020 Q1 | 5.05 Million ILS | 10.36% |
| 2019 Q1 | 7.55 Million ILS | 49.43% |
| 2019 Q2 | 4.21 Million ILS | -44.2% |
| 2019 Q3 | 4.56 Million ILS | 8.18% |
| 2019 Q4 | 4.57 Million ILS | 0.35% |
| 2019 FY | 20.9 Million ILS | 13.33% |
| 2018 Q4 | 5.05 Million ILS | 14.7% |
| 2018 Q3 | 4.4 Million ILS | 11.37% |
| 2018 Q2 | 3.95 Million ILS | -21.28% |
| 2018 Q1 | 5.02 Million ILS | 114.96% |
| 2018 FY | 18.45 Million ILS | -1.8% |
| 2017 Q2 | 3.58 Million ILS | 2.02% |
| 2017 Q1 | 3.51 Million ILS | 63.37% |
| 2017 Q3 | 9.35 Million ILS | 160.84% |
| 2017 FY | 18.78 Million ILS | 26.75% |
| 2017 Q4 | 2.33 Million ILS | -74.99% |
| 2016 Q3 | 6.31 Million ILS | 98.21% |
| 2016 Q4 | 2.15 Million ILS | -65.92% |
| 2016 Q1 | 3.17 Million ILS | -27.69% |
| 2016 Q2 | 3.18 Million ILS | 0.19% |
| 2016 FY | 14.82 Million ILS | 18.65% |
| 2015 FY | 12.49 Million ILS | 26.8% |
| 2015 Q2 | 2.92 Million ILS | 12.59% |
| 2015 Q1 | 2.59 Million ILS | -9.86% |
| 2015 Q4 | 4.39 Million ILS | 26.22% |
| 2015 Q3 | 3.48 Million ILS | 19.08% |
| 2014 Q1 | 3.18 Million ILS | -2.09% |
| 2014 Q4 | 2.88 Million ILS | 33.07% |
| 2014 Q3 | 2.16 Million ILS | -26.66% |
| 2014 Q2 | 2.95 Million ILS | -7.23% |
| 2014 FY | 9.85 Million ILS | 7.79% |
| 2013 FY | 9.14 Million ILS | 6.17% |
| 2013 Q1 | 2.1 Million ILS | 0.0% |
| 2013 Q4 | 3.25 Million ILS | 32.17% |
| 2013 Q3 | 2.45 Million ILS | 31.99% |
| 2013 Q2 | 1.86 Million ILS | -11.5% |
| 2012 FY | 8.61 Million ILS | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Matricelf Ltd | 11.78 Million ILA | -153.042% |